Table 2.
Summary of Surgery Types
| Surgery | Meloxicam IV 30 mg (n = 538) | Placebo (n = 183) | Overall (N = 721)a |
|---|---|---|---|
| Orthopedic surgeries, n (%) | |||
| Total knee replacement | 117 (21.7) | 39 (21.3) | 156 (21.6) |
| Complex foot | 52 (9.7) | 19 (10.4) | 71 (9.8) |
| Total hip replacement | 50 (9.3) | 18 (9.8) | 68 (9.4) |
| Bunionectomy | 40 (7.4) | 13 (7.1) | 53 (7.4) |
| Spinal | 10 (1.9) | 3 (1.6) | 13 (1.8) |
| Total shoulder replacement | 7 (1.3) | 1 (0.5) | 8 (1.1) |
| Complex shoulder surgery | 6 (1.1) | 2 (1.1) | 8 (1.1) |
| Total ankle replacement | 1 (0.2) | 0 | 1 (0.1) |
| Orthopedic trauma | 0 | 1 (0.5) | 1 (0.1) |
| Other surgery types, n (%) | |||
| Soft tissue surgery | 128 (23.8) | 42 (23.0) | 170 (23.6) |
| Gynecologic surgery | 68 (12.6) | 21 (11.5) | 89 (12.3) |
| Abdominoplasty | 32 (5.9) | 11 (6.0) | 43 (6.0) |
| GI surgery | 26 (4.8) | 13 (7.1) | 39 (5.4) |
| Head and neck | 1 (0.2) | 0 | 1 (0.1) |
GI indicates gastrointestinal; IV, intravenous.
a
Safety set (received at least 1 dose of study drug).